Paradigm Biopharmaceuticals Limited
Paradigm Biopharmaceuticals Limited (PBIGF) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · PBIGF · as of Jun 9, 2026
Key Statistics
Explore Paradigm Biopharmaceuticals Limited Data
pbigf stock data · financialsFinancial Snapshot
Full FinancialsCompetitors & Peers
pbigf competitorsPBIGF
AURX
IUGNF
KNTPF
MSCLF
ORXOFStock Performance
Full HistoryAbout Paradigm Biopharmaceuticals Limited
Paradigm Biopharmaceuticals Limited Melbourne, Australia-based Paradigm Biopharmaceuticals Limited operates as a drug repurposing company, focusing on the discovery and development of therapeutic products for human application. The comp…
what is paradigm biopharmaceuticals limited · pbigf stock overview · paradigm biopharmaceuticals limited company profile · who is paradigm biopharmaceuticals limited ceo · pbigf OTC · paradigm biopharmaceuticals limited headquarters · paradigm biopharmaceuticals limited business segments
About Stock Overview & Key Data
Paradigm Biopharmaceuticals Limited (PBIGF) is a Healthcare company in the Biotechnology industry, listed on OTC since May 10, 2019. As of the latest trading session, PBIGF stock price is $0.10, with a market capitalization of $45.5M. The stock has returned -59.13% over the past 12 months and -54.76% year-to-date.
In fiscal year 2025, Paradigm Biopharmaceuticals Limited reported revenue of $52120.00. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Paradigm Biopharmaceuticals Limited (PBIGF) stock price is $0.10. The stock is traded on OTC under the ticker symbol PBIGF. The 52-week range is $0.10 – $0.35.